Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Rett is the trial that will make Anavex a successful company.

If EXCELLENCE passes TLD muster, success for AVXL (assuming follow-up FDA approval) is in the bag no matter what else happens. I have run the numbers--revenues ramp quickly for a best-in-class drug at $300,000 to $400,000 a treatment.